Therefore, the additional analysis of these complications as determinants of retinal structure damage in addition to GH and IGF-I excess and tumor volume performed in this study is a further strength of this investigation, allowing to elucidate the role of the whole disease burden on retinal impairment. The gene discussed is IGF1; the disease is neoplasm.